nodes	percent_of_prediction	percent_of_DWPC	metapath
Ofloxacin—SLC22A5—Niacin—atherosclerosis	0.148	0.208	CbGbCtD
Ofloxacin—ABCC1—Rosuvastatin—atherosclerosis	0.133	0.186	CbGbCtD
Ofloxacin—ABCC2—Ezetimibe—atherosclerosis	0.0981	0.137	CbGbCtD
Ofloxacin—ABCC2—Simvastatin—atherosclerosis	0.0912	0.128	CbGbCtD
Ofloxacin—ABCC2—Pravastatin—atherosclerosis	0.0893	0.125	CbGbCtD
Ofloxacin—ABCC2—Lovastatin—atherosclerosis	0.0893	0.125	CbGbCtD
Ofloxacin—SLC22A6—Pravastatin—atherosclerosis	0.0653	0.0915	CbGbCtD
Ofloxacin—TOP2A—Fluvastatin—Rosuvastatin—atherosclerosis	0.00147	0.343	CbGdCrCtD
Ofloxacin—TOP2A—Simvastatin—Pravastatin—atherosclerosis	0.00141	0.328	CbGdCrCtD
Ofloxacin—TOP2A—Simvastatin—Lovastatin—atherosclerosis	0.00141	0.328	CbGdCrCtD
Ofloxacin—Muscle spasms—Simvastatin—atherosclerosis	0.000278	0.00124	CcSEcCtD
Ofloxacin—Vertigo—Lovastatin—atherosclerosis	0.000278	0.00124	CcSEcCtD
Ofloxacin—Angioedema—Ezetimibe—atherosclerosis	0.000277	0.00123	CcSEcCtD
Ofloxacin—Angiopathy—Niacin—atherosclerosis	0.000277	0.00123	CcSEcCtD
Ofloxacin—Leukopenia—Lovastatin—atherosclerosis	0.000277	0.00123	CcSEcCtD
Ofloxacin—Chills—Niacin—atherosclerosis	0.000274	0.00122	CcSEcCtD
Ofloxacin—Malaise—Ezetimibe—atherosclerosis	0.000274	0.00122	CcSEcCtD
Ofloxacin—Vision blurred—Simvastatin—atherosclerosis	0.000273	0.00121	CcSEcCtD
Ofloxacin—Arrhythmia—Niacin—atherosclerosis	0.000273	0.00121	CcSEcCtD
Ofloxacin—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.000271	0.00121	CcSEcCtD
Ofloxacin—Tremor—Simvastatin—atherosclerosis	0.000271	0.00121	CcSEcCtD
Ofloxacin—Alopecia—Niacin—atherosclerosis	0.00027	0.0012	CcSEcCtD
Ofloxacin—Chills—Pravastatin—atherosclerosis	0.00027	0.0012	CcSEcCtD
Ofloxacin—Insomnia—Rosuvastatin—atherosclerosis	0.000269	0.0012	CcSEcCtD
Ofloxacin—Ill-defined disorder—Simvastatin—atherosclerosis	0.000268	0.0012	CcSEcCtD
Ofloxacin—Arrhythmia—Pravastatin—atherosclerosis	0.000268	0.0012	CcSEcCtD
Ofloxacin—Palpitations—Ezetimibe—atherosclerosis	0.000268	0.00119	CcSEcCtD
Ofloxacin—Paraesthesia—Rosuvastatin—atherosclerosis	0.000268	0.00119	CcSEcCtD
Ofloxacin—Anaemia—Simvastatin—atherosclerosis	0.000267	0.00119	CcSEcCtD
Ofloxacin—Erythema—Niacin—atherosclerosis	0.000266	0.00118	CcSEcCtD
Ofloxacin—Malnutrition—Niacin—atherosclerosis	0.000266	0.00118	CcSEcCtD
Ofloxacin—Alopecia—Pravastatin—atherosclerosis	0.000266	0.00118	CcSEcCtD
Ofloxacin—Cough—Ezetimibe—atherosclerosis	0.000265	0.00118	CcSEcCtD
Ofloxacin—Angioedema—Simvastatin—atherosclerosis	0.000264	0.00118	CcSEcCtD
Ofloxacin—Myalgia—Lovastatin—atherosclerosis	0.000263	0.00117	CcSEcCtD
Ofloxacin—Chest pain—Lovastatin—atherosclerosis	0.000263	0.00117	CcSEcCtD
Ofloxacin—Arthralgia—Lovastatin—atherosclerosis	0.000263	0.00117	CcSEcCtD
Ofloxacin—Anxiety—Lovastatin—atherosclerosis	0.000262	0.00117	CcSEcCtD
Ofloxacin—Dyspepsia—Rosuvastatin—atherosclerosis	0.000262	0.00117	CcSEcCtD
Ofloxacin—Hypertension—Ezetimibe—atherosclerosis	0.000262	0.00117	CcSEcCtD
Ofloxacin—Flatulence—Niacin—atherosclerosis	0.000262	0.00117	CcSEcCtD
Ofloxacin—Malaise—Simvastatin—atherosclerosis	0.000261	0.00116	CcSEcCtD
Ofloxacin—Tension—Niacin—atherosclerosis	0.000261	0.00116	CcSEcCtD
Ofloxacin—Discomfort—Lovastatin—atherosclerosis	0.00026	0.00116	CcSEcCtD
Ofloxacin—Vertigo—Simvastatin—atherosclerosis	0.00026	0.00116	CcSEcCtD
Ofloxacin—Leukopenia—Simvastatin—atherosclerosis	0.000259	0.00115	CcSEcCtD
Ofloxacin—Myalgia—Ezetimibe—atherosclerosis	0.000258	0.00115	CcSEcCtD
Ofloxacin—Arthralgia—Ezetimibe—atherosclerosis	0.000258	0.00115	CcSEcCtD
Ofloxacin—Chest pain—Ezetimibe—atherosclerosis	0.000258	0.00115	CcSEcCtD
Ofloxacin—Nervousness—Niacin—atherosclerosis	0.000258	0.00115	CcSEcCtD
Ofloxacin—Flatulence—Pravastatin—atherosclerosis	0.000258	0.00115	CcSEcCtD
Ofloxacin—Dry mouth—Lovastatin—atherosclerosis	0.000258	0.00115	CcSEcCtD
Ofloxacin—Tension—Pravastatin—atherosclerosis	0.000257	0.00114	CcSEcCtD
Ofloxacin—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.000257	0.00114	CcSEcCtD
Ofloxacin—Dysgeusia—Pravastatin—atherosclerosis	0.000256	0.00114	CcSEcCtD
Ofloxacin—Muscle spasms—Niacin—atherosclerosis	0.000255	0.00114	CcSEcCtD
Ofloxacin—Discomfort—Ezetimibe—atherosclerosis	0.000255	0.00114	CcSEcCtD
Ofloxacin—Pain—Rosuvastatin—atherosclerosis	0.000255	0.00113	CcSEcCtD
Ofloxacin—Constipation—Rosuvastatin—atherosclerosis	0.000255	0.00113	CcSEcCtD
Ofloxacin—Confusional state—Lovastatin—atherosclerosis	0.000255	0.00113	CcSEcCtD
Ofloxacin—Nervousness—Pravastatin—atherosclerosis	0.000254	0.00113	CcSEcCtD
Ofloxacin—Dry mouth—Ezetimibe—atherosclerosis	0.000253	0.00112	CcSEcCtD
Ofloxacin—Anaphylactic shock—Lovastatin—atherosclerosis	0.000252	0.00112	CcSEcCtD
Ofloxacin—Muscle spasms—Pravastatin—atherosclerosis	0.000252	0.00112	CcSEcCtD
Ofloxacin—Infection—Lovastatin—atherosclerosis	0.000251	0.00112	CcSEcCtD
Ofloxacin—Vision blurred—Niacin—atherosclerosis	0.00025	0.00111	CcSEcCtD
Ofloxacin—Confusional state—Ezetimibe—atherosclerosis	0.00025	0.00111	CcSEcCtD
Ofloxacin—Anaphylactic shock—Ezetimibe—atherosclerosis	0.000248	0.0011	CcSEcCtD
Ofloxacin—Thrombocytopenia—Lovastatin—atherosclerosis	0.000247	0.0011	CcSEcCtD
Ofloxacin—Vision blurred—Pravastatin—atherosclerosis	0.000247	0.0011	CcSEcCtD
Ofloxacin—Arthralgia—Simvastatin—atherosclerosis	0.000246	0.0011	CcSEcCtD
Ofloxacin—Chest pain—Simvastatin—atherosclerosis	0.000246	0.0011	CcSEcCtD
Ofloxacin—Myalgia—Simvastatin—atherosclerosis	0.000246	0.0011	CcSEcCtD
Ofloxacin—Infection—Ezetimibe—atherosclerosis	0.000246	0.0011	CcSEcCtD
Ofloxacin—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000246	0.00109	CcSEcCtD
Ofloxacin—Anxiety—Simvastatin—atherosclerosis	0.000246	0.00109	CcSEcCtD
Ofloxacin—Tremor—Pravastatin—atherosclerosis	0.000245	0.00109	CcSEcCtD
Ofloxacin—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000244	0.00108	CcSEcCtD
Ofloxacin—Discomfort—Simvastatin—atherosclerosis	0.000243	0.00108	CcSEcCtD
Ofloxacin—Nervous system disorder—Ezetimibe—atherosclerosis	0.000243	0.00108	CcSEcCtD
Ofloxacin—Angioedema—Niacin—atherosclerosis	0.000243	0.00108	CcSEcCtD
Ofloxacin—Ill-defined disorder—Pravastatin—atherosclerosis	0.000243	0.00108	CcSEcCtD
Ofloxacin—Thrombocytopenia—Ezetimibe—atherosclerosis	0.000242	0.00108	CcSEcCtD
Ofloxacin—Anaemia—Pravastatin—atherosclerosis	0.000242	0.00108	CcSEcCtD
Ofloxacin—Anorexia—Lovastatin—atherosclerosis	0.000241	0.00107	CcSEcCtD
Ofloxacin—Skin disorder—Ezetimibe—atherosclerosis	0.000241	0.00107	CcSEcCtD
Ofloxacin—Angioedema—Pravastatin—atherosclerosis	0.000239	0.00106	CcSEcCtD
Ofloxacin—Vertigo—Niacin—atherosclerosis	0.000239	0.00106	CcSEcCtD
Ofloxacin—Syncope—Niacin—atherosclerosis	0.000238	0.00106	CcSEcCtD
Ofloxacin—Confusional state—Simvastatin—atherosclerosis	0.000238	0.00106	CcSEcCtD
Ofloxacin—Leukopenia—Niacin—atherosclerosis	0.000238	0.00106	CcSEcCtD
Ofloxacin—Urticaria—Rosuvastatin—atherosclerosis	0.000237	0.00105	CcSEcCtD
Ofloxacin—Oedema—Simvastatin—atherosclerosis	0.000236	0.00105	CcSEcCtD
Ofloxacin—Anaphylactic shock—Simvastatin—atherosclerosis	0.000236	0.00105	CcSEcCtD
Ofloxacin—Malaise—Pravastatin—atherosclerosis	0.000236	0.00105	CcSEcCtD
Ofloxacin—Abdominal pain—Rosuvastatin—atherosclerosis	0.000236	0.00105	CcSEcCtD
Ofloxacin—Vertigo—Pravastatin—atherosclerosis	0.000235	0.00105	CcSEcCtD
Ofloxacin—Palpitations—Niacin—atherosclerosis	0.000235	0.00105	CcSEcCtD
Ofloxacin—Infection—Simvastatin—atherosclerosis	0.000235	0.00104	CcSEcCtD
Ofloxacin—Leukopenia—Pravastatin—atherosclerosis	0.000234	0.00104	CcSEcCtD
Ofloxacin—Loss of consciousness—Niacin—atherosclerosis	0.000234	0.00104	CcSEcCtD
Ofloxacin—Cough—Niacin—atherosclerosis	0.000232	0.00103	CcSEcCtD
Ofloxacin—Thrombocytopenia—Simvastatin—atherosclerosis	0.000231	0.00103	CcSEcCtD
Ofloxacin—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.00023	0.00102	CcSEcCtD
Ofloxacin—Insomnia—Lovastatin—atherosclerosis	0.000228	0.00102	CcSEcCtD
Ofloxacin—Cough—Pravastatin—atherosclerosis	0.000228	0.00102	CcSEcCtD
Ofloxacin—Paraesthesia—Lovastatin—atherosclerosis	0.000227	0.00101	CcSEcCtD
Ofloxacin—Arthralgia—Niacin—atherosclerosis	0.000226	0.00101	CcSEcCtD
Ofloxacin—Myalgia—Niacin—atherosclerosis	0.000226	0.00101	CcSEcCtD
Ofloxacin—Hypertension—Pravastatin—atherosclerosis	0.000226	0.00101	CcSEcCtD
Ofloxacin—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.000226	0.001	CcSEcCtD
Ofloxacin—Anorexia—Simvastatin—atherosclerosis	0.000225	0.001	CcSEcCtD
Ofloxacin—Dyspnoea—Lovastatin—atherosclerosis	0.000225	0.001	CcSEcCtD
Ofloxacin—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.000225	0.001	CcSEcCtD
Ofloxacin—Insomnia—Ezetimibe—atherosclerosis	0.000224	0.000997	CcSEcCtD
Ofloxacin—Arthralgia—Pravastatin—atherosclerosis	0.000223	0.000991	CcSEcCtD
Ofloxacin—Chest pain—Pravastatin—atherosclerosis	0.000223	0.000991	CcSEcCtD
Ofloxacin—Myalgia—Pravastatin—atherosclerosis	0.000223	0.000991	CcSEcCtD
Ofloxacin—Paraesthesia—Ezetimibe—atherosclerosis	0.000222	0.00099	CcSEcCtD
Ofloxacin—Dyspepsia—Lovastatin—atherosclerosis	0.000222	0.000989	CcSEcCtD
Ofloxacin—Anxiety—Pravastatin—atherosclerosis	0.000222	0.000988	CcSEcCtD
Ofloxacin—Dry mouth—Niacin—atherosclerosis	0.000221	0.000985	CcSEcCtD
Ofloxacin—Dyspnoea—Ezetimibe—atherosclerosis	0.000221	0.000983	CcSEcCtD
Ofloxacin—Discomfort—Pravastatin—atherosclerosis	0.00022	0.00098	CcSEcCtD
Ofloxacin—Hypersensitivity—Rosuvastatin—atherosclerosis	0.00022	0.000977	CcSEcCtD
Ofloxacin—Decreased appetite—Lovastatin—atherosclerosis	0.000219	0.000977	CcSEcCtD
Ofloxacin—Dyspepsia—Ezetimibe—atherosclerosis	0.000218	0.00097	CcSEcCtD
Ofloxacin—Fatigue—Lovastatin—atherosclerosis	0.000218	0.000969	CcSEcCtD
Ofloxacin—Oedema—Niacin—atherosclerosis	0.000217	0.000965	CcSEcCtD
Ofloxacin—Anaphylactic shock—Niacin—atherosclerosis	0.000217	0.000965	CcSEcCtD
Ofloxacin—Pain—Lovastatin—atherosclerosis	0.000216	0.000961	CcSEcCtD
Ofloxacin—Constipation—Lovastatin—atherosclerosis	0.000216	0.000961	CcSEcCtD
Ofloxacin—Confusional state—Pravastatin—atherosclerosis	0.000215	0.000958	CcSEcCtD
Ofloxacin—Decreased appetite—Ezetimibe—atherosclerosis	0.000215	0.000958	CcSEcCtD
Ofloxacin—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000215	0.000958	CcSEcCtD
Ofloxacin—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000214	0.000952	CcSEcCtD
Ofloxacin—Asthenia—Rosuvastatin—atherosclerosis	0.000214	0.000952	CcSEcCtD
Ofloxacin—Insomnia—Simvastatin—atherosclerosis	0.000214	0.000951	CcSEcCtD
Ofloxacin—Anaphylactic shock—Pravastatin—atherosclerosis	0.000214	0.00095	CcSEcCtD
Ofloxacin—Oedema—Pravastatin—atherosclerosis	0.000214	0.00095	CcSEcCtD
Ofloxacin—Fatigue—Ezetimibe—atherosclerosis	0.000214	0.00095	CcSEcCtD
Ofloxacin—Shock—Niacin—atherosclerosis	0.000213	0.00095	CcSEcCtD
Ofloxacin—Infection—Pravastatin—atherosclerosis	0.000212	0.000944	CcSEcCtD
Ofloxacin—Paraesthesia—Simvastatin—atherosclerosis	0.000212	0.000944	CcSEcCtD
Ofloxacin—Pain—Ezetimibe—atherosclerosis	0.000212	0.000943	CcSEcCtD
Ofloxacin—Constipation—Ezetimibe—atherosclerosis	0.000212	0.000943	CcSEcCtD
Ofloxacin—Tachycardia—Niacin—atherosclerosis	0.000212	0.000942	CcSEcCtD
Ofloxacin—Pruritus—Rosuvastatin—atherosclerosis	0.000211	0.000938	CcSEcCtD
Ofloxacin—Skin disorder—Niacin—atherosclerosis	0.000211	0.000938	CcSEcCtD
Ofloxacin—Dyspnoea—Simvastatin—atherosclerosis	0.000211	0.000937	CcSEcCtD
Ofloxacin—Hyperhidrosis—Niacin—atherosclerosis	0.00021	0.000933	CcSEcCtD
Ofloxacin—Thrombocytopenia—Pravastatin—atherosclerosis	0.000209	0.000931	CcSEcCtD
Ofloxacin—Feeling abnormal—Lovastatin—atherosclerosis	0.000208	0.000926	CcSEcCtD
Ofloxacin—Dyspepsia—Simvastatin—atherosclerosis	0.000208	0.000925	CcSEcCtD
Ofloxacin—Anorexia—Niacin—atherosclerosis	0.000207	0.00092	CcSEcCtD
Ofloxacin—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000206	0.000919	CcSEcCtD
Ofloxacin—Hyperhidrosis—Pravastatin—atherosclerosis	0.000206	0.000919	CcSEcCtD
Ofloxacin—Decreased appetite—Simvastatin—atherosclerosis	0.000205	0.000914	CcSEcCtD
Ofloxacin—Feeling abnormal—Ezetimibe—atherosclerosis	0.000204	0.000908	CcSEcCtD
Ofloxacin—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000204	0.000908	CcSEcCtD
Ofloxacin—Diarrhoea—Rosuvastatin—atherosclerosis	0.000204	0.000907	CcSEcCtD
Ofloxacin—Fatigue—Simvastatin—atherosclerosis	0.000204	0.000906	CcSEcCtD
Ofloxacin—Anorexia—Pravastatin—atherosclerosis	0.000204	0.000906	CcSEcCtD
Ofloxacin—Hypotension—Niacin—atherosclerosis	0.000203	0.000902	CcSEcCtD
Ofloxacin—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000203	0.000901	CcSEcCtD
Ofloxacin—Constipation—Simvastatin—atherosclerosis	0.000202	0.000899	CcSEcCtD
Ofloxacin—Pain—Simvastatin—atherosclerosis	0.000202	0.000899	CcSEcCtD
Ofloxacin—Urticaria—Lovastatin—atherosclerosis	0.000201	0.000893	CcSEcCtD
Ofloxacin—Body temperature increased—Lovastatin—atherosclerosis	0.0002	0.000888	CcSEcCtD
Ofloxacin—Abdominal pain—Lovastatin—atherosclerosis	0.0002	0.000888	CcSEcCtD
Ofloxacin—Musculoskeletal discomfort—Niacin—atherosclerosis	0.000198	0.000879	CcSEcCtD
Ofloxacin—Dizziness—Rosuvastatin—atherosclerosis	0.000197	0.000877	CcSEcCtD
Ofloxacin—Urticaria—Ezetimibe—atherosclerosis	0.000197	0.000876	CcSEcCtD
Ofloxacin—Insomnia—Niacin—atherosclerosis	0.000196	0.000873	CcSEcCtD
Ofloxacin—Abdominal pain—Ezetimibe—atherosclerosis	0.000196	0.000871	CcSEcCtD
Ofloxacin—Body temperature increased—Ezetimibe—atherosclerosis	0.000196	0.000871	CcSEcCtD
Ofloxacin—Paraesthesia—Niacin—atherosclerosis	0.000195	0.000867	CcSEcCtD
Ofloxacin—Feeling abnormal—Simvastatin—atherosclerosis	0.000195	0.000866	CcSEcCtD
Ofloxacin—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000195	0.000866	CcSEcCtD
Ofloxacin—Dyspnoea—Niacin—atherosclerosis	0.000193	0.000861	CcSEcCtD
Ofloxacin—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000193	0.00086	CcSEcCtD
Ofloxacin—Insomnia—Pravastatin—atherosclerosis	0.000193	0.00086	CcSEcCtD
Ofloxacin—Somnolence—Niacin—atherosclerosis	0.000193	0.000858	CcSEcCtD
Ofloxacin—Paraesthesia—Pravastatin—atherosclerosis	0.000192	0.000853	CcSEcCtD
Ofloxacin—Dyspepsia—Niacin—atherosclerosis	0.000191	0.00085	CcSEcCtD
Ofloxacin—Dyspnoea—Pravastatin—atherosclerosis	0.00019	0.000847	CcSEcCtD
Ofloxacin—Decreased appetite—Niacin—atherosclerosis	0.000189	0.000839	CcSEcCtD
Ofloxacin—Dyspepsia—Pravastatin—atherosclerosis	0.000188	0.000837	CcSEcCtD
Ofloxacin—Rash—Rosuvastatin—atherosclerosis	0.000188	0.000836	CcSEcCtD
Ofloxacin—Dermatitis—Rosuvastatin—atherosclerosis	0.000188	0.000835	CcSEcCtD
Ofloxacin—Urticaria—Simvastatin—atherosclerosis	0.000188	0.000835	CcSEcCtD
Ofloxacin—Gastrointestinal disorder—Niacin—atherosclerosis	0.000187	0.000833	CcSEcCtD
Ofloxacin—Abdominal pain—Simvastatin—atherosclerosis	0.000187	0.000831	CcSEcCtD
Ofloxacin—Body temperature increased—Simvastatin—atherosclerosis	0.000187	0.000831	CcSEcCtD
Ofloxacin—Headache—Rosuvastatin—atherosclerosis	0.000187	0.000831	CcSEcCtD
Ofloxacin—Hypersensitivity—Lovastatin—atherosclerosis	0.000186	0.000828	CcSEcCtD
Ofloxacin—Decreased appetite—Pravastatin—atherosclerosis	0.000186	0.000826	CcSEcCtD
Ofloxacin—Pain—Niacin—atherosclerosis	0.000185	0.000825	CcSEcCtD
Ofloxacin—Fatigue—Pravastatin—atherosclerosis	0.000184	0.000819	CcSEcCtD
Ofloxacin—Pain—Pravastatin—atherosclerosis	0.000183	0.000813	CcSEcCtD
Ofloxacin—Constipation—Pravastatin—atherosclerosis	0.000183	0.000813	CcSEcCtD
Ofloxacin—Hypersensitivity—Ezetimibe—atherosclerosis	0.000182	0.000812	CcSEcCtD
Ofloxacin—Asthenia—Lovastatin—atherosclerosis	0.000181	0.000806	CcSEcCtD
Ofloxacin—Pruritus—Lovastatin—atherosclerosis	0.000179	0.000795	CcSEcCtD
Ofloxacin—Asthenia—Ezetimibe—atherosclerosis	0.000178	0.000791	CcSEcCtD
Ofloxacin—Gastrointestinal pain—Niacin—atherosclerosis	0.000177	0.000789	CcSEcCtD
Ofloxacin—Nausea—Rosuvastatin—atherosclerosis	0.000177	0.000788	CcSEcCtD
Ofloxacin—Feeling abnormal—Pravastatin—atherosclerosis	0.000176	0.000783	CcSEcCtD
Ofloxacin—Pruritus—Ezetimibe—atherosclerosis	0.000175	0.00078	CcSEcCtD
Ofloxacin—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000175	0.000777	CcSEcCtD
Ofloxacin—Hypersensitivity—Simvastatin—atherosclerosis	0.000174	0.000775	CcSEcCtD
Ofloxacin—Diarrhoea—Lovastatin—atherosclerosis	0.000173	0.000769	CcSEcCtD
Ofloxacin—Urticaria—Niacin—atherosclerosis	0.000172	0.000767	CcSEcCtD
Ofloxacin—Body temperature increased—Niacin—atherosclerosis	0.000171	0.000763	CcSEcCtD
Ofloxacin—Abdominal pain—Niacin—atherosclerosis	0.000171	0.000763	CcSEcCtD
Ofloxacin—Urticaria—Pravastatin—atherosclerosis	0.00017	0.000755	CcSEcCtD
Ofloxacin—Asthenia—Simvastatin—atherosclerosis	0.000169	0.000754	CcSEcCtD
Ofloxacin—Diarrhoea—Ezetimibe—atherosclerosis	0.000169	0.000754	CcSEcCtD
Ofloxacin—Abdominal pain—Pravastatin—atherosclerosis	0.000169	0.000751	CcSEcCtD
Ofloxacin—Body temperature increased—Pravastatin—atherosclerosis	0.000169	0.000751	CcSEcCtD
Ofloxacin—Pruritus—Simvastatin—atherosclerosis	0.000167	0.000744	CcSEcCtD
Ofloxacin—Dizziness—Lovastatin—atherosclerosis	0.000167	0.000743	CcSEcCtD
Ofloxacin—Dizziness—Ezetimibe—atherosclerosis	0.000164	0.000729	CcSEcCtD
Ofloxacin—Diarrhoea—Simvastatin—atherosclerosis	0.000162	0.000719	CcSEcCtD
Ofloxacin—Vomiting—Lovastatin—atherosclerosis	0.000161	0.000715	CcSEcCtD
Ofloxacin—Hypersensitivity—Niacin—atherosclerosis	0.00016	0.000711	CcSEcCtD
Ofloxacin—Rash—Lovastatin—atherosclerosis	0.000159	0.000709	CcSEcCtD
Ofloxacin—Dermatitis—Lovastatin—atherosclerosis	0.000159	0.000708	CcSEcCtD
Ofloxacin—Headache—Lovastatin—atherosclerosis	0.000158	0.000704	CcSEcCtD
Ofloxacin—Vomiting—Ezetimibe—atherosclerosis	0.000157	0.000701	CcSEcCtD
Ofloxacin—Hypersensitivity—Pravastatin—atherosclerosis	0.000157	0.0007	CcSEcCtD
Ofloxacin—Dizziness—Simvastatin—atherosclerosis	0.000156	0.000695	CcSEcCtD
Ofloxacin—Rash—Ezetimibe—atherosclerosis	0.000156	0.000695	CcSEcCtD
Ofloxacin—Dermatitis—Ezetimibe—atherosclerosis	0.000156	0.000694	CcSEcCtD
Ofloxacin—Asthenia—Niacin—atherosclerosis	0.000156	0.000693	CcSEcCtD
Ofloxacin—Headache—Ezetimibe—atherosclerosis	0.000155	0.000691	CcSEcCtD
Ofloxacin—Pruritus—Niacin—atherosclerosis	0.000153	0.000683	CcSEcCtD
Ofloxacin—Asthenia—Pravastatin—atherosclerosis	0.000153	0.000682	CcSEcCtD
Ofloxacin—Pruritus—Pravastatin—atherosclerosis	0.000151	0.000672	CcSEcCtD
Ofloxacin—Vomiting—Simvastatin—atherosclerosis	0.00015	0.000668	CcSEcCtD
Ofloxacin—Nausea—Lovastatin—atherosclerosis	0.00015	0.000668	CcSEcCtD
Ofloxacin—Rash—Simvastatin—atherosclerosis	0.000149	0.000663	CcSEcCtD
Ofloxacin—Dermatitis—Simvastatin—atherosclerosis	0.000149	0.000662	CcSEcCtD
Ofloxacin—Diarrhoea—Niacin—atherosclerosis	0.000148	0.00066	CcSEcCtD
Ofloxacin—Headache—Simvastatin—atherosclerosis	0.000148	0.000659	CcSEcCtD
Ofloxacin—Nausea—Ezetimibe—atherosclerosis	0.000147	0.000655	CcSEcCtD
Ofloxacin—Diarrhoea—Pravastatin—atherosclerosis	0.000146	0.00065	CcSEcCtD
Ofloxacin—Dizziness—Niacin—atherosclerosis	0.000143	0.000638	CcSEcCtD
Ofloxacin—Dizziness—Pravastatin—atherosclerosis	0.000141	0.000628	CcSEcCtD
Ofloxacin—Nausea—Simvastatin—atherosclerosis	0.00014	0.000624	CcSEcCtD
Ofloxacin—Vomiting—Niacin—atherosclerosis	0.000138	0.000614	CcSEcCtD
Ofloxacin—Rash—Niacin—atherosclerosis	0.000137	0.000609	CcSEcCtD
Ofloxacin—Dermatitis—Niacin—atherosclerosis	0.000137	0.000608	CcSEcCtD
Ofloxacin—Headache—Niacin—atherosclerosis	0.000136	0.000605	CcSEcCtD
Ofloxacin—Vomiting—Pravastatin—atherosclerosis	0.000136	0.000604	CcSEcCtD
Ofloxacin—Rash—Pravastatin—atherosclerosis	0.000135	0.000599	CcSEcCtD
Ofloxacin—Dermatitis—Pravastatin—atherosclerosis	0.000135	0.000599	CcSEcCtD
Ofloxacin—Headache—Pravastatin—atherosclerosis	0.000134	0.000595	CcSEcCtD
Ofloxacin—Nausea—Niacin—atherosclerosis	0.000129	0.000573	CcSEcCtD
Ofloxacin—Nausea—Pravastatin—atherosclerosis	0.000127	0.000565	CcSEcCtD
Ofloxacin—CYP1A2—Melatonin metabolism and effects—NFKB1—atherosclerosis	7.81e-05	0.00136	CbGpPWpGaD
Ofloxacin—ABCC1—Transmembrane transport of small molecules—ABCG5—atherosclerosis	7.74e-05	0.00135	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PTGS2—atherosclerosis	7.58e-05	0.00132	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—APOA5—atherosclerosis	7.54e-05	0.00131	CbGpPWpGaD
Ofloxacin—SLC22A4—Transmembrane transport of small molecules—HMOX1—atherosclerosis	7.3e-05	0.00127	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—PLA2G1B—atherosclerosis	7.26e-05	0.00127	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—LDLRAP1—atherosclerosis	7.17e-05	0.00125	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—ALOX5—atherosclerosis	7.01e-05	0.00122	CbGpPWpGaD
Ofloxacin—SLC22A5—Transmembrane transport of small molecules—PLAT—atherosclerosis	6.99e-05	0.00122	CbGpPWpGaD
Ofloxacin—SLC22A4—Transmembrane transport of small molecules—APOB—atherosclerosis	6.99e-05	0.00122	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—PLTP—atherosclerosis	6.74e-05	0.00118	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—NFKB1—atherosclerosis	6.58e-05	0.00115	CbGpPWpGaD
Ofloxacin—CYP1A2—Phase II conjugation—GSTM1—atherosclerosis	6.57e-05	0.00115	CbGpPWpGaD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—atherosclerosis	6.49e-05	0.00113	CbGpPWpGaD
Ofloxacin—SLC22A5—SLC-mediated transmembrane transport—ALB—atherosclerosis	6.48e-05	0.00113	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MAPK8—atherosclerosis	6.46e-05	0.00113	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—LIPC—atherosclerosis	6.25e-05	0.00109	CbGpPWpGaD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—atherosclerosis	6.22e-05	0.00108	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—APOC3—atherosclerosis	6.21e-05	0.00108	CbGpPWpGaD
Ofloxacin—TOP2A—Circadian rythm related genes—MAPK8—atherosclerosis	6.21e-05	0.00108	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—LDLR—atherosclerosis	6.17e-05	0.00108	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—LDLRAP1—atherosclerosis	6.12e-05	0.00107	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—CETP—atherosclerosis	6.03e-05	0.00105	CbGpPWpGaD
Ofloxacin—SLC22A6—Transmembrane transport of small molecules—CETP—atherosclerosis	5.99e-05	0.00104	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—VEGFA—atherosclerosis	5.97e-05	0.00104	CbGpPWpGaD
Ofloxacin—SLC22A5—Transmembrane transport of small molecules—PLG—atherosclerosis	5.94e-05	0.00104	CbGpPWpGaD
Ofloxacin—SLC22A4—Transmembrane transport of small molecules—PPARA—atherosclerosis	5.9e-05	0.00103	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—ABCG8—atherosclerosis	5.85e-05	0.00102	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—LTA4H—atherosclerosis	5.85e-05	0.00102	CbGpPWpGaD
Ofloxacin—CYP1A2—Arachidonic acid metabolism—PTGS2—atherosclerosis	5.82e-05	0.00101	CbGpPWpGaD
Ofloxacin—ABCC2—Transmembrane transport of small molecules—CETP—atherosclerosis	5.8e-05	0.00101	CbGpPWpGaD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—atherosclerosis	5.79e-05	0.00101	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—SCARB1—atherosclerosis	5.77e-05	0.00101	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PLTP—atherosclerosis	5.75e-05	0.001	CbGpPWpGaD
Ofloxacin—ABCC1—Transmembrane transport of small molecules—CETP—atherosclerosis	5.73e-05	0.000999	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MAPK3—atherosclerosis	5.65e-05	0.000984	CbGpPWpGaD
Ofloxacin—SLC22A4—Transmembrane transport of small molecules—APOA1—atherosclerosis	5.53e-05	0.000964	CbGpPWpGaD
Ofloxacin—SLC22A5—Transmembrane transport of small molecules—HMOX1—atherosclerosis	5.49e-05	0.000957	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TGFB1—atherosclerosis	5.48e-05	0.000955	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—HMGCR—atherosclerosis	5.45e-05	0.000951	CbGpPWpGaD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—atherosclerosis	5.4e-05	0.000941	CbGpPWpGaD
Ofloxacin—SLC22A6—Transmembrane transport of small molecules—PLAT—atherosclerosis	5.28e-05	0.00092	CbGpPWpGaD
Ofloxacin—SLC22A5—Transmembrane transport of small molecules—APOB—atherosclerosis	5.25e-05	0.000916	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TNF—atherosclerosis	5.12e-05	0.000892	CbGpPWpGaD
Ofloxacin—ABCC2—Transmembrane transport of small molecules—PLAT—atherosclerosis	5.11e-05	0.000891	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—APOA4—atherosclerosis	5.09e-05	0.000888	CbGpPWpGaD
Ofloxacin—ABCC1—Transmembrane transport of small molecules—PLAT—atherosclerosis	5.05e-05	0.000881	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—ABCG8—atherosclerosis	4.99e-05	0.000869	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—LTA4H—atherosclerosis	4.99e-05	0.000869	CbGpPWpGaD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—atherosclerosis	4.9e-05	0.000854	CbGpPWpGaD
Ofloxacin—SLC22A6—SLC-mediated transmembrane transport—ALB—atherosclerosis	4.89e-05	0.000853	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—ABCA1—atherosclerosis	4.86e-05	0.000847	CbGpPWpGaD
Ofloxacin—ABCC2—NRF2 pathway—TGFB1—atherosclerosis	4.76e-05	0.000829	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—ABCG1—atherosclerosis	4.62e-05	0.000806	CbGpPWpGaD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—atherosclerosis	4.5e-05	0.000784	CbGpPWpGaD
Ofloxacin—SLC22A6—Transmembrane transport of small molecules—PLG—atherosclerosis	4.49e-05	0.000782	CbGpPWpGaD
Ofloxacin—SLC22A5—Transmembrane transport of small molecules—PPARA—atherosclerosis	4.43e-05	0.000773	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—APOA2—atherosclerosis	4.38e-05	0.000764	CbGpPWpGaD
Ofloxacin—SLC22A4—Transmembrane transport of small molecules—ALB—atherosclerosis	4.38e-05	0.000764	CbGpPWpGaD
Ofloxacin—ABCC2—Transmembrane transport of small molecules—PLG—atherosclerosis	4.35e-05	0.000758	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—FABP4—atherosclerosis	4.35e-05	0.000758	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—LCAT—atherosclerosis	4.35e-05	0.000758	CbGpPWpGaD
Ofloxacin—ABCC1—Transmembrane transport of small molecules—PLG—atherosclerosis	4.3e-05	0.000749	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—APOA4—atherosclerosis	4.27e-05	0.000744	CbGpPWpGaD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—atherosclerosis	4.2e-05	0.000732	CbGpPWpGaD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—TNF—atherosclerosis	4.2e-05	0.000732	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—CYP7A1—atherosclerosis	4.19e-05	0.000731	CbGpPWpGaD
Ofloxacin—SLC22A5—Transmembrane transport of small molecules—APOA1—atherosclerosis	4.16e-05	0.000725	CbGpPWpGaD
Ofloxacin—SLC22A6—Transmembrane transport of small molecules—HMOX1—atherosclerosis	4.14e-05	0.000722	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—BGN—atherosclerosis	4.05e-05	0.000706	CbGpPWpGaD
Ofloxacin—ABCC2—Transmembrane transport of small molecules—HMOX1—atherosclerosis	4.01e-05	0.000699	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	3.99e-05	0.000696	CbGpPWpGaD
Ofloxacin—SLC22A6—Transmembrane transport of small molecules—APOB—atherosclerosis	3.97e-05	0.000692	CbGpPWpGaD
Ofloxacin—ABCC1—Transmembrane transport of small molecules—HMOX1—atherosclerosis	3.96e-05	0.000691	CbGpPWpGaD
Ofloxacin—TOP2A—Circadian rythm related genes—IL6—atherosclerosis	3.96e-05	0.000691	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—ABCG1—atherosclerosis	3.94e-05	0.000687	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—CYP27A1—atherosclerosis	3.87e-05	0.000675	CbGpPWpGaD
Ofloxacin—ABCC2—Transmembrane transport of small molecules—APOB—atherosclerosis	3.84e-05	0.00067	CbGpPWpGaD
Ofloxacin—CYP1A2—Biological oxidations—GSTM1—atherosclerosis	3.84e-05	0.00067	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	3.81e-05	0.000665	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—AKT1—atherosclerosis	3.81e-05	0.000664	CbGpPWpGaD
Ofloxacin—ABCC1—Transmembrane transport of small molecules—APOB—atherosclerosis	3.8e-05	0.000662	CbGpPWpGaD
Ofloxacin—CYP1A2—Metapathway biotransformation—GSTM1—atherosclerosis	3.79e-05	0.000661	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	3.72e-05	0.000649	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—FABP4—atherosclerosis	3.71e-05	0.000646	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—LCAT—atherosclerosis	3.71e-05	0.000646	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—ALOX5AP—atherosclerosis	3.67e-05	0.00064	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—APOA2—atherosclerosis	3.67e-05	0.00064	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—PLA2G2A—atherosclerosis	3.67e-05	0.00064	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—ALOX15—atherosclerosis	3.67e-05	0.00064	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—APOA4—atherosclerosis	3.64e-05	0.000634	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—ABCG5—atherosclerosis	3.63e-05	0.000632	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	3.62e-05	0.000632	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CYP7A1—atherosclerosis	3.57e-05	0.000623	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—CST3—atherosclerosis	3.53e-05	0.000616	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—LPA—atherosclerosis	3.5e-05	0.000611	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—BGN—atherosclerosis	3.39e-05	0.000592	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	3.37e-05	0.000587	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—APOA5—atherosclerosis	3.36e-05	0.000586	CbGpPWpGaD
Ofloxacin—SLC22A6—Transmembrane transport of small molecules—PPARA—atherosclerosis	3.35e-05	0.000583	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—NAMPT—atherosclerosis	3.34e-05	0.000583	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CYP27A1—atherosclerosis	3.3e-05	0.000576	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—APOC3—atherosclerosis	3.3e-05	0.000576	CbGpPWpGaD
Ofloxacin—SLC22A5—Transmembrane transport of small molecules—ALB—atherosclerosis	3.29e-05	0.000574	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—LDLR—atherosclerosis	3.28e-05	0.000572	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	3.26e-05	0.000569	CbGpPWpGaD
Ofloxacin—ABCC2—Transmembrane transport of small molecules—PPARA—atherosclerosis	3.24e-05	0.000565	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—PLA2G1B—atherosclerosis	3.23e-05	0.000564	CbGpPWpGaD
Ofloxacin—ABCC1—Transmembrane transport of small molecules—PPARA—atherosclerosis	3.2e-05	0.000558	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	3.2e-05	0.000557	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—HSPA1B—atherosclerosis	3.17e-05	0.000553	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	3.17e-05	0.000552	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	3.16e-05	0.000551	CbGpPWpGaD
Ofloxacin—SLC22A6—Transmembrane transport of small molecules—APOA1—atherosclerosis	3.14e-05	0.000547	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—APOA2—atherosclerosis	3.13e-05	0.000546	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—ALOX15—atherosclerosis	3.13e-05	0.000546	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G2A—atherosclerosis	3.13e-05	0.000546	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—ALOX5AP—atherosclerosis	3.13e-05	0.000546	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—ALOX5—atherosclerosis	3.12e-05	0.000544	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—ABCG5—atherosclerosis	3.09e-05	0.000539	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—NCF1—atherosclerosis	3.07e-05	0.000535	CbGpPWpGaD
Ofloxacin—ABCC2—Transmembrane transport of small molecules—APOA1—atherosclerosis	3.04e-05	0.00053	CbGpPWpGaD
Ofloxacin—ABCC1—Transmembrane transport of small molecules—APOA1—atherosclerosis	3e-05	0.000524	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—LPA—atherosclerosis	2.99e-05	0.000521	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—CYBA—atherosclerosis	2.89e-05	0.000503	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	2.88e-05	0.000503	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—APOA5—atherosclerosis	2.86e-05	0.000499	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—PARP1—atherosclerosis	2.83e-05	0.000493	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—NAMPT—atherosclerosis	2.8e-05	0.000488	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	2.78e-05	0.000485	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—LIPC—atherosclerosis	2.78e-05	0.000485	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—APOC3—atherosclerosis	2.77e-05	0.000482	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G1B—atherosclerosis	2.76e-05	0.000481	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—LDLR—atherosclerosis	2.75e-05	0.000479	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle, Mitotic—MAPK3—atherosclerosis	2.73e-05	0.000477	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—LDLRAP1—atherosclerosis	2.72e-05	0.000475	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—CETP—atherosclerosis	2.68e-05	0.000468	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—ALOX5—atherosclerosis	2.66e-05	0.000464	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—SCARB1—atherosclerosis	2.57e-05	0.000448	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—PLTP—atherosclerosis	2.56e-05	0.000447	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	2.5e-05	0.000436	CbGpPWpGaD
Ofloxacin—SLC22A6—Transmembrane transport of small molecules—ALB—atherosclerosis	2.49e-05	0.000434	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle—MAPK3—atherosclerosis	2.44e-05	0.000426	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—HMGCR—atherosclerosis	2.43e-05	0.000423	CbGpPWpGaD
Ofloxacin—ABCC2—Transmembrane transport of small molecules—ALB—atherosclerosis	2.41e-05	0.00042	CbGpPWpGaD
Ofloxacin—ABCC1—Transmembrane transport of small molecules—ALB—atherosclerosis	2.38e-05	0.000415	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—LIPC—atherosclerosis	2.37e-05	0.000414	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—APOC3—atherosclerosis	2.36e-05	0.000411	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—LDLR—atherosclerosis	2.34e-05	0.000409	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CETP—atherosclerosis	2.29e-05	0.000399	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—ABCG8—atherosclerosis	2.22e-05	0.000387	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—LTA4H—atherosclerosis	2.22e-05	0.000387	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—SCARB1—atherosclerosis	2.19e-05	0.000382	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	2.19e-05	0.000382	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—ABCA1—atherosclerosis	2.16e-05	0.000377	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—APOB—atherosclerosis	2.12e-05	0.00037	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—HMGCR—atherosclerosis	2.07e-05	0.000361	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—LPL—atherosclerosis	2.03e-05	0.000354	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—PRKCG—atherosclerosis	1.97e-05	0.000344	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—HMOX1—atherosclerosis	1.86e-05	0.000324	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—ABCA1—atherosclerosis	1.85e-05	0.000322	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—MTHFR—atherosclerosis	1.83e-05	0.000318	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—APOB—atherosclerosis	1.78e-05	0.00031	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—PDGFB—atherosclerosis	1.78e-05	0.00031	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—ABCG1—atherosclerosis	1.76e-05	0.000306	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—GSTM1—atherosclerosis	1.73e-05	0.000302	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—APOE—atherosclerosis	1.7e-05	0.000296	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—LPL—atherosclerosis	1.7e-05	0.000296	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—CAV1—atherosclerosis	1.68e-05	0.000294	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—APOA1—atherosclerosis	1.68e-05	0.000293	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—GPX1—atherosclerosis	1.66e-05	0.000289	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—LCAT—atherosclerosis	1.65e-05	0.000288	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—FABP4—atherosclerosis	1.65e-05	0.000288	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—APOA4—atherosclerosis	1.62e-05	0.000282	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—CD36—atherosclerosis	1.61e-05	0.000281	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—CYP7A1—atherosclerosis	1.59e-05	0.000277	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—NOS2—atherosclerosis	1.58e-05	0.000276	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—MTHFR—atherosclerosis	1.53e-05	0.000267	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	1.52e-05	0.000264	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—PPARA—atherosclerosis	1.5e-05	0.000262	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—CYP27A1—atherosclerosis	1.47e-05	0.000256	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—AGT—atherosclerosis	1.45e-05	0.000253	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—INS—atherosclerosis	1.45e-05	0.000253	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	1.45e-05	0.000252	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—APOE—atherosclerosis	1.42e-05	0.000248	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	1.41e-05	0.000246	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—CAV1—atherosclerosis	1.41e-05	0.000246	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—APOA1—atherosclerosis	1.41e-05	0.000245	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—APOA2—atherosclerosis	1.39e-05	0.000243	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—PLA2G2A—atherosclerosis	1.39e-05	0.000243	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—ALOX15—atherosclerosis	1.39e-05	0.000243	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—ALOX5AP—atherosclerosis	1.39e-05	0.000243	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—ABCG5—atherosclerosis	1.38e-05	0.00024	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	1.38e-05	0.00024	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—SERPINE1—atherosclerosis	1.33e-05	0.000233	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—LPA—atherosclerosis	1.33e-05	0.000232	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—BGN—atherosclerosis	1.29e-05	0.000225	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—PIK3CG—atherosclerosis	1.28e-05	0.000224	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	1.28e-05	0.000223	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—APOA5—atherosclerosis	1.28e-05	0.000222	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—NOS3—atherosclerosis	1.27e-05	0.000222	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—PPARG—atherosclerosis	1.24e-05	0.000216	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	1.24e-05	0.000216	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—PLA2G1B—atherosclerosis	1.23e-05	0.000214	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—INS—atherosclerosis	1.22e-05	0.000212	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	1.21e-05	0.000212	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	1.2e-05	0.00021	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	1.2e-05	0.000209	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—ALOX5—atherosclerosis	1.19e-05	0.000207	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—PTGS2—atherosclerosis	1.16e-05	0.000203	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—ALB—atherosclerosis	1.11e-05	0.000194	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	1.1e-05	0.000191	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—NOS3—atherosclerosis	1.07e-05	0.000186	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—NAMPT—atherosclerosis	1.06e-05	0.000185	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	1.06e-05	0.000184	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—LIPC—atherosclerosis	1.06e-05	0.000184	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—APOC3—atherosclerosis	1.05e-05	0.000183	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—LDLR—atherosclerosis	1.04e-05	0.000182	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—CETP—atherosclerosis	1.02e-05	0.000178	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—SCARB1—atherosclerosis	9.76e-06	0.00017	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—PTGS2—atherosclerosis	9.75e-06	0.00017	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	9.51e-06	0.000166	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—HMGCR—atherosclerosis	9.22e-06	0.000161	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—STAT3—atherosclerosis	9.08e-06	0.000158	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—MAPK3—atherosclerosis	8.68e-06	0.000151	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—TGFB1—atherosclerosis	8.42e-06	0.000147	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	8.32e-06	0.000145	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—ABCA1—atherosclerosis	8.22e-06	0.000143	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—HMOX1—atherosclerosis	7.05e-06	0.000123	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—APOB—atherosclerosis	6.75e-06	0.000118	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—GSTM1—atherosclerosis	6.57e-06	0.000115	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—LPL—atherosclerosis	6.45e-06	0.000112	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—IL6—atherosclerosis	6.34e-06	0.000111	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—GPX1—atherosclerosis	6.29e-06	0.00011	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—CD36—atherosclerosis	6.13e-06	0.000107	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—AKT1—atherosclerosis	5.85e-06	0.000102	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—MTHFR—atherosclerosis	5.81e-06	0.000101	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—PPARA—atherosclerosis	5.7e-06	9.93e-05	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—AGT—atherosclerosis	5.52e-06	9.62e-05	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—APOE—atherosclerosis	5.41e-06	9.43e-05	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—CAV1—atherosclerosis	5.36e-06	9.34e-05	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—APOA1—atherosclerosis	5.34e-06	9.32e-05	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—AKT1—atherosclerosis	4.9e-06	8.55e-05	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—PIK3CG—atherosclerosis	4.88e-06	8.51e-05	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—PPARG—atherosclerosis	4.71e-06	8.21e-05	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—INS—atherosclerosis	4.62e-06	8.05e-05	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—ALB—atherosclerosis	4.23e-06	7.38e-05	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—NOS3—atherosclerosis	4.05e-06	7.06e-05	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—PTGS2—atherosclerosis	3.7e-06	6.46e-05	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—AKT1—atherosclerosis	1.86e-06	3.25e-05	CbGpPWpGaD
